
Cecilia Monge B, MD
@ceciliamonge4
National Cancer Institute, National Institutes of Health, views are my own
ID: 883776499433820161
08-07-2017 19:55:12
1,1K Tweet
1,1K Followers
4,4K Following

Honored by the invitation to co-host this Session with Lewis Roberts at the Cholangiocarcinoma Conference - FASEB in California in August, see you there! Mayo Clinic Comprehensive Cancer Center @NCIResearchCtr National Cancer Institute NCI CCR Med Onc Service FASEB



The importance to educate in gastric cancer risk factors and symptoms. Congrats LEGACyH2020 Mexico 🇲🇽 team Erika Ruiz-Garcia #gastriccancerprevention 🙌🏻World Congress on Gastrointestinal Cancer


Lenvatinib Plus Pembrolizumab vs Regorafenib or TAS for Previously Treated mCRC: Phase 3 LEAP-017 Study at #WCGIC2023 👉mOS: 9.8 vs 9.3 mo 👉There is some activity, but⛔️ 👉IO in MSS CRC remains a challenge... World Congress on Gastrointestinal Cancer ESMO - Eur. Oncology OncoAlert


Dr. Pellini discusses ctDNA use for maintenance outcomes in patients with NSCLC treated with A + CP DAVA Oncology #DAVAHawaiiLung



Excited to see this published: Current Landscape of Therapies for Hepatocellular Carcinoma academic.oup.com/carcin/article… Tim Greten grateful to Kelley Coffman D’Annibale MD @changqingxie Shadin Ghabra @donnamabry @NCIResearchCtr National Cancer Institute NCI CCR Med Onc Service

Proud to be part of the review on the current landscape in the treatments available for early, intermediate, and advanced stage #HCC! Cecilia Monge B, MD Tim Greten Kelley Coffman D’Annibale MD Changqing Xie


I get to learn from some of the best. Lots of laughter, many celebrations, and plenty of debates over the past year with this great team in GI malignancies at the NCI! Happy to see our work together come through. NCI CCR Med Onc Service


Underrepresentation of Hispanics -Liver Cancer Phase III Trials Tim Greten J. Alberto Maldonado, MS4 @KatherineAMcGlynn @NCIResearchCtr NCI CCR Med Onc Service #healthdisparities #livercancer #Hispanic Hispanic individuals in liver cancer trial representation | JHC Dove Medical Press dovepress.com/hispanic-indiv…

Are Our Clinical Trials at the National Cancer Institute Right for You: Liver Cancer youtu.be/hS0XXudBeEY via YouTube Tim Greten Donna Hrones @NCIResearchCtr NIH NCI CCR Med Onc Service #livercancer


A tour de force State-of-the-art lecture by Tim Greten at Cholangiocarcinoma Foundation basic science track - From Mice to Men and Back to Mice: Basic and Translational Research Studies in CCA. Highlighting the importance of using the right preclinical models + patient data in a complementary manner.



The Importance of Health Disparities in Liver Cancer in the Hispanic Population Thank you to Maureen Umeh for the invitation and interview Tim Greten Dr. Rob Winn Winn Awards NIH National Cancer Institute #fox5DC app.box.com/s/2ys3c8bin51i…


Our own Dr Cecilia Monge B, MD NCI CCR Med Onc Service showcasing her work on CRC genomic research inclusion #AACRdisp24


We begin our International Symposium on Gastroesophageal Cancer "Deciphering Treatment" with our first speaker: professor Cecilia Monge from National Cancer Institute talks about the present and future of molecular classification in gastric cancer.


Excelente presentacion en el Instituto Nacional de Cancerologia de Mexico Diego Felipe Ballen


That’s a wrap! What an amazing experience to share with colleagues and top notch experts from Mexico and around the world focusing on better outcomes for patients with esophagogastric cancer. A true world-class multidisciplinary meeting thanks to our chairs Erika Ruiz-Garcia A.Takahashi MD, MHA
